Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Combination formula for treating inflammatory bowel disease

An inflammatory bowel disease and formula technology, which is applied in the field of combined formula of Chinese medicinal materials and amino acids, can solve the problems of large side effects and unsatisfactory effects, and achieve good therapeutic effects, prolong human life, and enhance blood supply

Inactive Publication Date: 2016-03-23
何松庆
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory and have large side effects. Therefore, it is an urgent task for the medical community to study the etiology of inflammatory bowel disease, find the cause of the disease, and take corresponding treatment measures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] 1. 0.5 grams of Ganoderma lucidum, 0.5 grams of threonine, and 1.2 grams of glutamine are made into chewing agents, 2 to 4 times a day.

[0025] 2. 0.25 grams of Ganoderma lucidum, 0.25 grams of threonine, and 0.6 grams of glutamine are made into chewing agents, 2 to 4 times a day.

[0026] 3. 0.5 grams of Ganoderma lucidum, 0.5 grams of threonine, and 1.2 grams of glutamine are made into medicines, 2 to 4 times a day.

[0027] 4. 0.25 grams of Ganoderma lucidum, 0.25 grams of threonine, and 0.6 grams of glutamine are made into medicines, 2 to 4 times a day.

[0028] 5. 5 grams of Ganoderma lucidum, 0.5 grams of threonine, and 1.2 grams of glutamine are made into oral preparations, 2 to 4 times a day.

[0029] Sixth, 2.5 grams of Ganoderma lucidum, 0.25 grams of threonine, and 0.6 grams of glutamine are made into oral agents, 2 to 4 times a day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a combination formula for treating inflammatory bowel disease, and belongs to the field of drugs. The principle of the formula lies in that abnormal immune response and inflammation are prevented by reinforcing intestinal epithelial goblet cells, constructing a normal intestinal tract surface mucous layer barrier, as well as preventing intestine antigen from getting close to, being in contact with, being adhered to, and entering intestinal tissues; ganoderma lucidum has the efficacies of strengthening human body blood supply and human body oxygen supply; L-threonine is the constituent part of mucoprotein and essential amino-acid of the human body, and glutamine is the main energy source of intestinal mucosa. The combination formula provided by the invention provides nutrients, oxygen and raw materials for goblet cells for development, renewal and repairing as well as secretion of mucoprotein to form the intestinal tract surface mucous layer barrier; the three-in-one formula further has obvious effects of constructing the normal human body intestinal tract surface mucous layer barrier, eliminating inflammation and repairing intestinal tissues, thereby being an effective formula for treating inflammatory bowel disease.

Description

technical field [0001] The invention relates to a combined formula of Chinese medicinal materials and amino acids for treating inflammatory bowel disease, and belongs to the field of medicines. Background technique [0002] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. Because the cause of the disease and the pathogenesis have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the disease. [0003] Medical immunology believes that the immune system has abnormal recognition and tolerance to antigens, that is, it produces an immune response to the abnormal recognition of normal intestinal microorganisms, causing the disease. Histology and embryology believe that the high permeability of the intestinal mucosa leads to a large number of intestinal antigens entering the intestinal wall tissue, triggering a long-term response of the immune system and...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/074A61P1/00A61P1/12A61P11/06A61P11/02A61K31/198
CPCA61K36/074A61K9/0053A61K9/0056A61K31/198A61K2300/00
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com